Indicators of risk for serious hypoglycemia in patients with type 1 Diabetes mellitus;Risikoindikatoren für das auftreten schwerer hypoglykämien bei patienten mit typ-1-Diabetes mellitus

Diabetes und Stoffwechsel

Volumn 11, Issue 4, 2002, Pages 145-149

  Hermanns, N ^a   Kulzer, B ^a   Maier, B ^a   Kubiak, T ^a   Haak, T ^a  

^a Forsch Inst der Diabetes Akademie   (Germany)

Author keywords

C peptide; Glycemic control; Hypoglycemia; Type 1 diabetes

Indexed keywords

C PEPTIDE;

ADULT; AGED; ARTICLE; AWARENESS; DIABETES CONTROL; DISEASE SEVERITY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; POLYNEUROPATHY; RISK ASSESSMENT;

EID: 0036324241     PISSN: 09420037     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Hypoglycemia is the limiting factor in the management of IDDM
2. Dead-in-bed syndrome in young diabetic patients
3. Driving decrements in type I diabetes during moderate hypoglycemia
4. Mortality
5. Hypoglycemia in the diabetes control and complication trial
6. Unawareness of hypoglycaemia in insulin-treated diabetic patients: Prevalence and relationship to automatic neuropathy
7. Intensified insulin therapy and the risk of severe hypoglycemia
8. Effect of intensive insulin therapy on glycemic thresholds for counteregulatory hormone release
9. The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin-dependent diabetes mellitus
10. Frequencies causes and treatment of hypoglycaemia
11. Differential effects of duration of diabetes and glycemic control on thresholds and magnitudes of responses to hypoglycemia
12. Altered hierarchy of protective responses against severe hypoglycemia in normal aging healthy men
13. Impaired hypoglycaemia awareness
14. Hypoglykämie
15. How to ameliorate the problem of hypoglycemia in intensive as well as nonintensive treatment of type-1-diabetes
16. Epidemiologie der peripheren diabetischen Neuropathie
17. Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial
18. Long term function (6 years) of islet allografts in type 1 diabetes
19. Restoration of hypoglycemia awareness in patients with long duration insulin dependent diabetes
20. Meticulous prevention of hypoglycemia normalizes the glycemic thresholds and magnitude of most neuroendocrine responses to symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short term IDDM
21. Reversal of hypoglycemia unawareness, but not defective glucose counterregulation, in IDDM
22. Effects and correlates of blood glucose awareness training among patients with IDDM
23. A muticentarevaluation of blood glucose awareness training II